Poolbeg Pharma PLC (AIM:POLB)
London · Delayed Price · Currency is GBP · Price in GBX 4.000
0.00 (0.00%)
At close: Dec 31, 2025
Poolbeg Pharma Market Cap
Poolbeg Pharma has a market cap or net worth of 27.89 million as of December 31, 2025. Its market cap has decreased by -24.11% in one year.
Market Cap
27.89M
Enterprise Value
17.93M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4.00
Market Cap Chart
Since July 19, 2021, Poolbeg Pharma's market cap has decreased from 53.75M to 27.89M, a decrease of -48.12%. That is a compound annual growth rate of -13.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 27.89M | -21.44% |
| Dec 31, 2024 | 35.50M | -21.55% |
| Dec 29, 2023 | 45.25M | 49.59% |
| Dec 30, 2022 | 30.25M | -36.32% |
| Dec 31, 2021 | 47.50M | -11.63% |
| Jul 19, 2021 | 53.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 213.19B |
| GSK plc | 73.15B |
| Haleon | 33.22B |
| Smith & Nephew | 10.37B |
| Convatec Group | 4.64B |
| Hikma Pharmaceuticals | 3.39B |
| Genus | 1.73B |
| HUTCHMED (China) | 1.71B |